HOME >> BIOLOGY >> NEWS
Combination therapy drives cancer into remission

Researchers have achieved an experimental breakthrough in the simultaneous use of two or more agents for treating cancer, known as combination therapy. If it is shown to be safe and effective in humans, the therapy outlined by the new study is a promising general strategy for treating many cancers that do not respond to current therapies.

A two-drug combination therapy, published in tomorrow's issue of the journal Nature, led to the complete remission of a mouse model of B-cell lymphoma in all of the treated animals. In contrast, animals treated with either drug alone (rapamycin or doxorubicin) rarely experienced complete remission.

The study, led by Dr. Scott Lowe of Cold Spring Harbor Laboratory, establishes a new paradigm for overcoming chemotherapy resistance in many forms of cancer.

Rational Target Selection and an Off-the-Shelf Chemotherapeutic "One-Two Punch" for Lymphoma and Other Cancers

Pre-cancerous cells can be eliminated from the body by a natural self-destruct mechanism--normally active in many types of cells--called programmed cell death. Unfortunately, a hallmark of most cancers is a defect in programmed cell death that enables pre-cancerous cells to survive, proliferate out of control, and form a tumor.

Because most traditional chemotherapy agents act by triggering programmed cell death, such agents are frequently ineffective against tumors that lack a functional programmed cell death mechanism. Such tumors are said to be chemotherapy-resistant. The evasion of treatment-induced programmed cell death by chemotherapy-resistant tumors has been a major impediment to successful therapeutic outcomes for human cancer.

Lowe and his colleagues reasoned that--like a one-two knockout punch in boxing--using one drug to restore the programmed cell death mechanism and a second drug to trigger the process might reduce or eliminate chemotherapy-resistance and be an effective strategy for treating cancer.
'"/>

Contact: Jeff Picarello
picarell@cshl.edu
516-367-8486
Cold Spring Harbor Laboratory
17-Mar-2004


Page: 1 2 3 4

Related biology news :

1. Combination of gene therapy and gene silencing prevents neurodegenerative disease
2. Combination therapy dramatically improves function after spinal cord injury in rats
3. Combination drug therapy drastically reduces multiple coronary heart disease risk factors
4. Combination therapy improves anthrax survival
5. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
6. Combination Therapy For Brain Tumors Holds Promise For Longer Survival After Surgery
7. New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions
8. Dangerous Chemical Combination Presents Possible Scenario For Gulf War Illnesses
9. Targeted therapy knocks out pediatric brain cancer in mice
10. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
11. Columbia research to examine gene influence on severity of peridontal disease, therapy response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2020)... OLDSMAR, Fla. (PRWEB) , ... June 08, 2020 ... ... increased demand for masks and other protective measures to protect workers in the ... doctors and their dedicated staffs who valiantly risk their lives every day to ...
(Date:6/5/2020)... (PRWEB) , ... June 04, 2020 , ... “Although we ... health and well-being of our attendees, staff, and the public. We remain committed ... and safe ways to collaborate virtually,” said Julie Sutcliffe, President of WMIS. ...
(Date:5/30/2020)... ... May 29, 2020 , ... eInfochips, a ... globally, has collaborated with EchoNous Inc. to develop the cloud-based connected health KOSMOS ... heart function, which has been clinically tested versus expert measurements, yielding improved results ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/7/2020)... ... 2020 , ... Bio-IT World has announced the winners of ... University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were ... outstanding examples of how technology innovations and strategic initiatives can be powerful forces ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider ... for businesses of all types to ensure cleanliness, distancing and occupancy with its patent ... Safe Space™ enabled business will provide a health performance index system that scores all ...
Breaking Biology Technology:
Cached News: